The study, led by IDIBAPS researchers, also demonstrates the role of the molecule in vascular function.
News about Idibaps
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Daily consumption of walnuts reduces “bad" cholesterol and improves the quality of low-density lipoprotein (LDL)
The Hospital Clínic-IDIBAPS is carrying out a trial to explore the effects of a diet enriched with walnuts for two years on healthy ageing in individuals...
IDIBAPS researchers describe, for the first time, the role of ductular reaction in the formation of new blood vessels.
The study, published in the journal Molecular Metabolism, has involved the participation of IDIBAPS researchers.
How does real-world handling affect protein drugs? Hospital Clínic researchers participate in the International RealHOPE project, funded by the IMI (Innovative Medicines Initiative) and EFPIA.
The goal of the project is to find out the critical factors that destabilise protein drugs during their handling at hospitals and patients’ homes.
Researchers from the IIBB-CSIC-IDIBAPS participate in a study that shows the interaction of the receptor for cannabinoids with the BiP protein in terminals of inhibitory neurons, modulating anxiety
The findings open a new conceptual framework to understand the striking context-dependent pharmacological actions of cannabis in the brain.
A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy. It...
Low levels of antibodies for the S protein of SARS-CoV-2 are associated with a higher risk of death in critical COVID-19 patients
The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.
IDIBAPS signs the transparency agreement on the use of animals in scientific experimentation in Spain
The transparency agreement on the use of animals in scientific experimentation in Spain is a document promoted by the Spanish Confederation of Scientific...
European Depression Day: Treatment-resistant depression gains 44,000 new sufferers every year in Spain
A study by CIBERSAM with the participation of Hospital Clínic-IDIBAPS found that treatment-resistant depression has a mean incidence in Spain of 0.93 cases...